Positives

• A patient with rheumatoid arthritis and persistent SARS-CoV-2 antigen reported significant resolution of brain fog, fatigue, and headache during IL-6R blockade, with brain fog returning when treatment was paused and resolving again on resumption PMC.
  
  
• Patients with severe inflammatory arthritis describe meaningful drops in joint pain, stiffness, and the fatigue that comes with high IL-6 activity within the first weeks of dosing Drugs.com.
  
  

Negatives

• A patient who paused IL-6R blockade developed new-onset cognitive symptoms in addition to her prior post-COVID issues, suggesting durable benefit may require continuous dosing PMC.
  
  
• Several users report neutropenia, transaminase elevations, and recurrent upper respiratory infections that forced interruptions in their dosing schedule Drugs.com.
  
  

Hurdles & Side Effects

• A patient seeking IL-6R blockade for post-viral symptoms found that no rheumatologist would prescribe it without an autoimmune diagnosis, since Long COVID is not a labeled indication Drugs.com.
  
  
• Mandatory baseline TB screening, lipid panels, and monthly liver/CBC monitoring add appointment burden that exhausted patients struggle to coordinate Drugs.com.